文献速递传染病防控与疫情报告卫生政策与健康促进

医疗补助扩展对HIV诊断与暴露前预防用药的影响

Effect of Medicaid Expansions on HIV Diagnoses and Pre-Exposure Prophylaxis Use.
PubMed 文献 · Am J Prev Med · 2021-01-25

本研究采用双重差分设计,评估《平价医疗法案》推动的医疗补助扩展对HIV诊断率、HIV状态知晓率和暴露前预防用药的影响。结果显示,医疗补助扩展与HIV诊断率增加0.508/10万(13.9%,p=0.037)相关,尤其在注射吸毒感染及低收入农村县;同时HIV状态知晓率和暴露前预防用药有所改善,淋病发病率下降。结论提示扩大公共医疗保险可能有助于遏制HIV流行。

要点

  • 医疗补助扩展与HIV诊断率增加13.9%相关,尤其在注射吸毒感染和低收入农村县。
  • 扩展还改善了HIV状态知晓率和暴露前预防用药使用。
  • 未发现对HIV发病率、物质使用或性传播感染率的影响,但淋病发病率下降。

核心结论

  • 医疗补助扩展与HIV诊断率增加、HIV状态知晓率提高和暴露前预防用药使用增加相关,扩大公共医疗保险可能是遏制HIV流行的途径。

研究设计与样本

  • 采用双重差分设计,比较扩展医疗补助州的所有县(处理县)与未扩展州的所有县(对照县)在扩展前后HIV诊断率、HIV状态知晓率和暴露前预防用药的变化。
  • 分析于2019年8月至2020年7月进行。

主要发现

  • 医疗补助扩展与HIV诊断率增加0.508/10万(13.9%,p=0.037)相关,尤其在注射吸毒感染和低收入、农村、扩展前未保险率高的县。
  • 医疗补助扩展与HIV状态知晓率和暴露前预防用药使用改善相关。
  • 未发现对HIV发病率、物质使用或性传播感染率的影响,但淋病发病率在扩展后下降。

关键数值与推荐

  • HIV诊断率增加0.508/10万(13.9%,p=0.037)。

临床怎么用

  • 扩大公共医疗保险可能通过提高HIV状态知晓率和暴露前预防用药使用来辅助控制HIV流行。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Increased insurance coverage and access to health care can increase identification of undiagnosed HIV infection and use of HIV prevention services such as pre-exposure prophylaxis. This study investigates whether the Medicaid expansions facilitated by the Affordable Care Act had these effects. METHODS: A difference-in-differences design was used to estimate the effects of the Medicaid expansions using data on HIV diagnoses per 100,000 population, awareness of HIV status, and pre-exposure prophylaxis use. The analyses involved first calculating differences in new diagnoses and pre-exposure prophylaxis use before and after the expansions and then comparing these differences between treatment counties (i.e., all counties in states that expanded Medicaid) and control counties (i.e., all counties in states that did not expand Medicaid). Further analyses to investigate mechanisms addressed associations with HIV incidence, rates of sexually transmitted infections, and substance use. Analyses were conducted between August 2019 and July 2020. RESULTS: Medicaid expansions were associated with an increase in HIV diagnoses of 0.508 per 100,000 population, or 13.9% (p=0.037), particularly for infections contracted via injection drug use and among low-income, rural counties with a high share of pre-Affordable Care Act uninsured rates that were most likely to be affected by the expansions. In addition, Medicaid expansions were associated with improvements in the knowledge of HIV status and pre-exposure prophylaxis use. There was no impact of the expansions on incident HIV, substance use, or sexually transmitted infection rates with the exception of gonorrhea, which decreased after the expansions. Altogether, these results suggest that the changes in new HIV diagnoses, awareness of HIV status, and pre-exposure prophylaxis were not simply because of a higher incidence or an increase in infection risk. CONCLUSIONS: Medicaid expansions were associated with increases in the percentage of people living with HIV who are aware of their status and pre-exposure prophylaxis use. Expanding public health insurance may be an avenue for curbing the HIV epidemic.

来源:Am J Prev Med,查看原文。版权归原作者所有。

引用

  1. Fayaz Farkhad B, Holtgrave DR, Albarracín D, et al. Effect of Medicaid Expansions on HIV Diagnoses and Pre-Exposure Prophylaxis Use. Am J Prev Med. 2021. PMID: 33509564. doi:10.1016/j.amepre.2020.10.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。